PCV56 COST-EFFECTIVENESS OF DABIGATRAN ETEXILATE 150 MG FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM IN PATIENTS UNDERGOING TOTAL HIP OR KNEE ARTHROPLASTY THAT HAVE MODERATE IMPAIRMENT OF RENAL FUNCTION

May 1, 2009, 00:00 AM
10.1016/S1098-3015(10)73818-3
https://www.valueinhealthjournal.com/article/S1098-3015(10)73818-3/fulltext
Section Title :
Section Order : 287
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)73818-3&doi=10.1016/S1098-3015(10)73818-3
HEOR Topics :
Tags :
Regions :